See also this year's filing and all EDGAR filings for this company.
PDF Report 0001730430_2019_Kiniksa_Pharmaceuticals_International_plc.pdf
Logs
Graph
Absolute values for 0001730430, Kiniksa Pharmaceuticals International plc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 313,750,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,356,000 |
| 3 | remainder_Assets | 1,859,000 |
| 4 | LiabilitiesCurrent | 42,554,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 144,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 21,563,000 |
| 9 | ResearchAndDevelopmentExpense | 86,597,000 |
| 10 | remainder_Expenses | -214,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 4,719,000 |
| 13 | remainder_ComprehensiveNetIncome | -4,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 321,965,000 |
| 1 | Liabilities | 42,698,000 |
| 2 | Expenses | 107,946,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 279,267,000 |
| 5 | NetIncome | -103,227,000 |
| 6 | ComprehensiveNetIncome | -103,229,000 |
| 7 | BaseVar | 238,666,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.77 |
| 9 | EconomicCapitalRatio | 3.54 |